Procalcitonin to initiate or withhold antibiotics in acute respiratory tract infections

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2008, Pages

  Schuetz, Philipp ^a   Briel, Matthias ^b   Christ Crain, Mirjam ^a   Wolbers, Marcel ^b   Stolz, Daiana ^a   Tamm, Michael ^a   Bucher, Heiner ^b   Müller, Beat ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; PROCALCITONIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC THERAPY; CALCITONIN BLOOD LEVEL; CLINICAL TRIAL; EMPYEMA; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MEDICAL DECISION MAKING; MEDICAL RECORD; META ANALYSIS; MORTALITY; PARAPNEUMONIC EFFUSION; PHARYNGEAL ABSCESS; PNEUMONIA; PRACTICE GUIDELINE; PROGNOSIS; RESPIRATORY TRACT INFECTION; RETROPHARYNGEAL ABSCESS; REVIEW; SIDE EFFECT; SINUSITIS; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT PLANNING; TREATMENT WITHDRAWAL;

EID: 55049135622     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007498     Document Type: Review

References (25)

1. Assmann 2000 Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000;355 (9209):1064-9.
2. Briel 2005 Briel M, Christ-Crain M, Young J, Schuetz P, Huber P, Periat P, et al. Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN73182671]. BMC Family Practice 2005;6:34.
3. Brookes 2004 Brookes ST, Whitely E, Egger M, Smith GD, Mulheran PA, Peters TJ. Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test. Journal of Clinical Epidemiology 2004;57(3):229-36.
4. Christ-Crain 2004 Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, et al.Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004;363 (9409):600-7.
5. Christ-Crain 2006 Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR, et al.Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. American Journal of Respiratory and Critical Care Medicine 2006;174(1):84-93.
6. Dixon 1985 Dixon RE. Economic costs of respiratory tract infections in the United States. American Journal of Medicine 1985;78(6B):45-51.
7. Evans 2002 Evans AT, Husain S, Durairaj L, Sadowski LS, Charles-Damte M, Wang Y. Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial. Lancet 2002;359(9318):1648-54.
8. Fine 1997 Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al.A prediction rule to identify low-risk patients with community-acquired pneumonia. New England Journal of Medicine 1997; 336(4):243-50.
9. Gonzales 1997 Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997;278(11):901-4.
10. Goossens 2005 Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365(9459):579-87.
11. Hoare 2006 Hoare Z, Lim WS. Pneumonia: update on diagnosis and management. BMJ 2006;332(7549):1077-9.
12. Little 1997 Little P, Williamson I, Warner G, Gould C, Gantley M, Kinmonth AL. Open randomised trial of prescribing strategies in managing sore throat. BMJ 1997;314(7082):722-7.
13. Macfarlane 1993 Macfarlane JT, Colville A, Guion A, Macfarlane RM, Rose DH. Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community. Lancet 1993;341:511-4.
14. Morgenthaler 2002 Morgenthaler NG, Struck J, Fischer-Schulz C, Seidel-Mueller E, Beier W, Bergmann A. Detection of procalcitonin (PCT) in healthy controls and patients with local infection by a sensitive ILMA. Clinical Laboratory 2002;48(5-6):263-70.
15. Morgenthaler 2003 Morgenthaler NG, Struck J, Chancerelle Y, Weglohner W, Agay D, Bohuon C, et al.Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection. Hormone and Metabolic Research 2003;35 (5):290-5.
16. Muller 2000 Muller B, Becker KL, Schachinger H, Rickenbacher PR, Huber PR, Zimmerli W, et al.Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Critical Care Medicine 2000;28(4):977-83.
17. Muller 2001 Muller B, Becker KL. Procalcitonin: howa hormone became amarker and m ediator of sepsis. Swiss Medical Weekly 2001;131(41-2):595-602.
18. Muller 2007 Muller B, Christ-Crain M, Schuetz P. Meta-analysis of procalcitonin for sepsis detection. Lancet Infectious Diseases 2007;7(8):498-9; author reply 502-3.
19. Nylen 2003 Nylen ES, Muller B, Becker KL, Snyder RH. The future diagnostic role of procalcitonin levels: the need for improved sensitivity. Clinical Infectious Diseases 2003;36:823-4.
20. Simmonds 2005 Simmonds MC, Higgins JP, Stewart LA, Tierney JF, Clarke MJ, Thompson SG. Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clinical Trials 2005;2(3):209-17.
21. Stolz 2006 Stolz D, Christ-Crain M, Gencay MM, Bingisser R, Huber PR, Muller B, et al.Diagnostic value of signs, symptoms and laboratory values in lower respiratory tract infection. Swiss Medical Weekly 2006; 136(27-8):434-40.
22. Stolz 2007 Stolz D, Christ-Crain M, Bingisser R, Leuppi J, Miedinger D, Muller C, et al.Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 2007;131(1):9-19.
23. Thompson 2001 Thompson SG, Turner RM, Warn DE. Multilevel models for meta-analysis, and their application to absolute risk differences. Statistical Methods in Medical Research 2001;10(6):375-92.
24. Turner 2000 Turner RM, Omar RZ, Yang M, Goldstein H, Thompson SG. A multilevel model framework for meta-analysis of clinical trials with binary outcomes. Statistics in Medicine 2000;19(24):3417-32.
25. Whang 1998 Whang KT, Steinwald PM, White JC, Nylen ES, Snider RH, Simon GL, et al.Serum calcitonin precursors in sepsis and systemic inflammation. Journal of Clinical Endocrinology and Metabolism 1998;83(9):3296- 301.